Home > Category > Signaling Pathways > Immunology & Inflammation > CTLA-4 > Anti-CTLA4 (ipilimumab biosimilar) mAb

Anti-CTLA4 (ipilimumab biosimilar) mAb

ChemLeader 98+%

Catalog No：CLA1010 CAS No.：477202-00-9 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$850.00	Visible after login	- +
5 mg	3-5days	$3300.00	Visible after login	- +
10 mg	3-5days	$5500.00	Visible after login	- +
50 mg	3-5days	$22000.00	Visible after login	- +
100 mg	3-5days	$42000.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Anti-CTLA4 (ipilimumab biosimilar) mAb
CAS	477202-00-9
Appearance	Colorless to light yellow (Solution)
Storage condition	Sealed and Store at -80°C. Aliquots should be stored at the same temperature after first use to avoid freeze-thaw cycles

Product details

Ipilimumab (MDX-010) is a fully human monoclonal IgG1κ antibody against the cytotoxic T-lymphocyte antigen-4 (CTLA-4), an immune-inhibitory molecule expressed in activated T cells and in suppressor T regulatory cells.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1010

Anti-CTLA4 (ipilimumab biosimilar) mAb

477202-00-9 98+%

CLA1154

Otilimab (Synonyms: GSK 3196165; MOR103)

1638332-55-4 95+%

CL2169

Revaprazan hydrochloride; Revaprazan HCl

178307-42-1 98+%